Lee's Pharmaceutical Holdings Balance Sheet Health
Financial Health criteria checks 5/6
Lee's Pharmaceutical Holdings has a total shareholder equity of HK$2.0B and total debt of HK$192.8M, which brings its debt-to-equity ratio to 9.8%. Its total assets and total liabilities are HK$2.9B and HK$930.1M respectively. Lee's Pharmaceutical Holdings's EBIT is HK$36.0M making its interest coverage ratio 3.7. It has cash and short-term investments of HK$171.0M.
Key information
9.8%
Debt to equity ratio
HK$192.76m
Debt
| Interest coverage ratio | 3.7x |
| Cash | HK$171.00m |
| Equity | HK$1.96b |
| Total liabilities | HK$930.07m |
| Total assets | HK$2.89b |
Recent financial health updates
Recent updates
Optimistic Investors Push Lee's Pharmaceutical Holdings Limited (HKG:950) Shares Up 28% But Growth Is Lacking
Dec 20
Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01
May 21Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01
Apr 02Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01
Aug 29Does Lee's Pharmaceutical Holdings (HKG:950) Have A Healthy Balance Sheet?
Apr 05Can Mixed Fundamentals Have A Negative Impact on Lee's Pharmaceutical Holdings Limited (HKG:950) Current Share Price Momentum?
Mar 17Should You Buy Lee's Pharmaceutical Holdings Limited (HKG:950) For Its 0.9% Dividend?
Feb 22What Type Of Returns Would Lee's Pharmaceutical Holdings'(HKG:950) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?
Jan 29What Type Of Shareholders Own The Most Number of Lee's Pharmaceutical Holdings Limited (HKG:950) Shares?
Jan 12Have Insiders Sold Lee's Pharmaceutical Holdings Limited (HKG:950) Shares Recently?
Dec 22Don't Ignore The Fact That This Insider Just Sold Some Shares In Lee's Pharmaceutical Holdings Limited (HKG:950)
Dec 08
Is Lee's Pharmaceutical Holdings Limited's (HKG:950) Recent Price Movement Underpinned By Its Weak Fundamentals?
Dec 01Is Lee's Pharmaceutical Holdings Limited (HKG:950) A Strong Dividend Stock?
Nov 18Financial Position Analysis
Short Term Liabilities: 950's short term assets (HK$656.6M) exceed its short term liabilities (HK$648.8M).
Long Term Liabilities: 950's short term assets (HK$656.6M) exceed its long term liabilities (HK$281.3M).
Debt to Equity History and Analysis
Debt Level: 950's net debt to equity ratio (1.1%) is considered satisfactory.
Reducing Debt: 950's debt to equity ratio has increased from 5.8% to 9.8% over the past 5 years.
Debt Coverage: 950's debt is well covered by operating cash flow (57.1%).
Interest Coverage: 950's interest payments on its debt are well covered by EBIT (3.7x coverage).